Eurofins Scientific SE (EPA:ERF)
France
· Delayed Price · Currency is EUR | Market Cap | 12.03B |
| Revenue (ttm) | 7.30B |
| Net Income (ttm) | 416.10M |
| Shares Out | 176.45M |
| EPS (ttm) | 2.23 |
| PE Ratio | 30.57 |
| Forward PE | 16.97 |
| Dividend | 0.72 (1.06%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 357,208 |
| Average Volume | 316,656 |
| Open | 66.96 |
| Previous Close | 68.16 |
| Day's Range | 66.84 - 68.48 |
| 52-Week Range | 45.56 - 74.32 |
| Beta | 0.96 |
| RSI | 53.65 |
| Earnings Date | Mar 2, 2026 |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include susta... [Read more]
Financial Performance
In 2025, Eurofins Scientific SE's revenue was 7.30 billion, an increase of 4.96% compared to the previous year's 6.95 billion. Earnings were 416.10 million, an increase of 16.78%.
Financial StatementsNews
Eurofins Scientific : Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification ...
Eurofins Scientific: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification ...
Eurofins Scientific: Weak Organic Growth Cyclical, Growth Will Normalize
Sequoia Fund reviews its 2025 performance and top holdings like Eurofins Scientific. Read the full Q4 shareholder letter for detailed investment insights.
Eurofins Scientific SE (ERFSF) Full Year 2025 Earnings Call Highlights: Strong Performance ...
Eurofins Scientific SE (ERFSF) Full Year 2025 Earnings Call Highlights: Strong Performance Amidst Challenges
Full Year 2025 Eurofins Scientific SE Earnings Call Transcript
Full Year 2025 Eurofins Scientific SE Earnings Call Transcript
Eurofins Scientific SE (ERFSF) Q4 2025 Earnings Call Transcript
Eurofins Scientific SE (ERFSF) Q4 2025 Earnings Call Transcript
Eurofins Scientific SE: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification ...
Eurofins Scientific SE: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification...
Eurofins Scientific: Growth, Repurchase Program, And Low Debt Make An Excellent Combination
Eurofins has a repurchase program that contemplates buying back up to 4.5% of its share capital from April 2025 to April 2026. The company expects that its revenues will grow by approximately 8.6% thi...
Eurofins Scientific SE (ERFSF) Q3 2025 Sales Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q3 2025 Sales Call October 21, 2025 9:00 AM EDT Company Participants Gilles Martin - Chairman of the Board & CEO Laurent Lebras - Group Administration & CFO Confer...
What Worked In Q2: Longleaf's Most Impactful Global Holdings
Glanbia rebounded as market concerns over input costs and competition eased, with strategic divestitures and buybacks supporting undervaluation thesis. Eurofins benefited from organic growth, accelera...
Eurofins Scientific SE (ERFSF) Q2 2025 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q2 2025 Earnings Conference Call July 23, 2025 9:00 AM ET Company Participants Gilles Martin - Chairman of the Board & CEO Laurent Lebras - Group Administration & ...
Eurofins Scientific: Anticipate Revenue Growth And Margin Expansion By 2027
Eurofins Scientific delivered strong Q1 revenue growth and robust 2024 cash flow, supporting confidence in its 2025 and 2027 guidance. The company is executing well on organic growth and M&A, with a c...
Eurofins Scientific SE (ERFSF) Q4 2024 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q4 2024 Earnings Call Transcript January 30, 2025 9:00 AM ET Company Participants Gilles Martin - Chairman of the Board & Chief Executive Officer Laurent Lebras - ...
Eurofins Scientific: Strong Cash Flows Will Fund M&A To Boost EBITDA Growth
Eurofins Scientific's EBITDA fell post COVID, but growth is expected to resume with aggressive targets, making the stock appealing despite recent setbacks. The company confirmed its 2024 outlook, expe...
Eurofins Scientific SE (ERFSF) Q3 2024 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q3 2024 Results Conference Call October 22, 2024 9:00 AM ET Company Participants Dr. Gilles Martin - Chief Executive Officer Laurent Lebras - Chief Financial Offic...
Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA
Eurofins Scientific faced a short attack by Muddy Waters but has since recovered, maintaining strong financials and cash flow despite the initial share price drop. The company reported a net profit of...
Eurofins Scientific SE (ERFSF) Q2 2024 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q2 2024 Earnings Call July 24, 2024 9:00 AM ET Company Participants Gilles Martin - Chief Executive Officer Laurent Lebras - Chief Financial Officer Conference Cal...
Eurofins Scientific announces the acquisition of Labormar, further expanding its presence in Latin America and its Food and Feed, Environmental, Cosmetic and Pharmacological testing offering in Colombia
BARRANQUILLA, Colombia--(BUSINESS WIRE)--The Eurofins network of companies, a world leader in food, environment, pharmaceutical and cosmetic product testing, announces the completion of the acquisitio...
Eurofins Scientific's stock drops on allegations from short-seller Muddy Waters
Eurofins Scientific shares plunged on Monday after Muddy Waters Research said in a report it had started shorting the laboratory-services company, alleging founder and Chief Executive Gilles Martin ha...
Eurofins Scientific SE (ERFSF) Q1 2024 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Gilles Martin - Chairman and CEO Conference Call Participants Suhasini Varanasi - G...
Eurofins Scientific SE (ERFSF) Q4 2023 Earnings Call Transcript
Eurofins Scientific SE (ERFSF) Q4 2023 Earnings Call Transcript
Eurofins Scientific Is A Growth Story That Has Reached Fair Valuation Again
Eurofins Scientific is delivering a 10% growth without relying on exuberant COVID-related margins. The company boasts a robust business model, a significant market share, and a reliable and trustworth...
Eurofins Scientific Announces the Acquisition of Quasfar, Establishing a Presence in Colombia and Expanding the Presence of Eurofins Laboratories in Latin America
LUXEMBOURG--(BUSINESS WIRE)--The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced m...